Oxygenation deterioration and computed tomography findings in acute exacerbation of interstitial lung diseases: a prospective observational study [0.03%]
急性间质性肺病加重的血氧恶化与CT表现之间的关系：一项前瞻性观察研究
Toru Arai,Junji Otsuka,Shinobu Akagawa et al.
Toru Arai et al.
Background: Acute exacerbation (AE) is a critical prognostic event in interstitial lung diseases (ILDs), initially recognized in idiopathic pulmonary fibrosis (IPF). Current AE diagnostic criteria do not account for oxyge...
Feasibility testing of a smartphone application for visualizing and sharing peak flow monitoring data in asthma evaluation [0.03%]
用于哮喘评估的峰值流量监测数据可视化和共享的智能手机应用程序的可行性测试
Kotaro Sasahara,Yuma Sakai,Katsunori Masaki et al.
Kotaro Sasahara et al.
Background: Adherence to peak expiratory flow monitoring in asthma management is low because of the burden of data recording. We developed a smartphone application that helps record and monitor patients' daily PEF. ...
Real-world clinical data on adult respiratory syncytial virus infection in a Japanese community hospital: Emphasis on positivity rate, older adults, and pneumonia cases [0.03%]
日本社区医院成人呼吸道合胞病毒感染的真实世界临床数据：重点介绍阳性率、老年人和肺炎病例
Hiroyuki Honda,Koji Kuronuma,Yutaro Nagano et al.
Hiroyuki Honda et al.
Background: Information on the incidence and clinical characteristics of respiratory syncytial virus (RSV) infections among adults remains limited in Japan. In this study, we aimed to clarify these aspects among adult out...
Corrigendum to "Transcutaneous CO2 and O2 monitoring during walking with a high-flow nasal cannula in patients with chronic obstructive pulmonary disease" [Respir Invest, Volume 63, Issue 5, September 2025, Pages 887-897] [0.03%]
慢性阻塞性肺疾病患者高流量鼻导管步行期间经皮CO2和O2监测的勘误表(原载于《呼吸调查》[Respir Investig]第63卷，第5期，2025年9月，887-897页)
Akira Umeda,Akane Morito,Masahiro Ishizaka et al.
Akira Umeda et al.
Published Erratum
Respiratory investigation. 2026 Jan 10:101366. DOI:10.1016/j.resinv.2025.101366 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial [0.03%]
布瑞舒坦治疗非囊性纤维化支气管扩张的日本患者：ASPEN试验的事后分析
Kozo Morimoto,James D Chalmers,Pierre-Régis Burgel et al.
Kozo Morimoto et al.
Background: In the ASPEN trial (NCT04594369), brensocatib 10 mg and 25 mg significantly reduced the burden of pulmonary exacerbations (annualized rate [primary endpoint], time to first, proportion exacerbation-free) over ...
All-case post-marketing surveillance of delamanid for treating multidrug-resistant pulmonary tuberculosis in Japan [0.03%]
日本贝达喹啉治疗耐多药肺结核上市后再评价研究
Toru Mori,Kazunari Tsuyuguchi,Takefumi Saito et al.
Toru Mori et al.
Background: Delamanid is a nitro-dihydro-imidazooxazole derivative that possesses highly potent activity against Mycobacterium tuberculosis, including strains linked to multidrug-resistant tuberculosis (MDR-TB). We conduc...
Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis [0.03%]
日本间质性肺疾病的流行病学：全国数据库分析
Koichi Miyashita,Yusuke Inoue,Hideki Yasui et al.
Koichi Miyashita et al.
Background: Interstitial lung disease (ILD) comprises a wide range of pulmonary disorders associated with high morbidity and mortality. Although idiopathic pulmonary fibrosis (IPF) has been the focus of much prior researc...
Identifying high-risk smokers without airflow limitation using new COPD criteria: pooled analysis of two Japanese cohorts [0.03%]
使用新的COPD标准识别无气流阻塞的高危吸烟者：两项日本队列研究的汇总分析
Naoya Tanabe,Shotaro Chubachi,Kunihiko Terada et al.
Naoya Tanabe et al.
Background: Recently proposed multidimensional chronic obstructive pulmonary disease (COPD) diagnostic criteria incorporate computed tomography (CT) findings and symptoms beyond airflow limitation. These criteria, develop...
Summary of the Japanese Respiratory Society guidelines for the diagnosis and treatment of asthma and chronic obstructive pulmonary disease overlap 2023 (2nd edition) [0.03%]
日本呼吸器学会哮喘和慢性阻塞性肺疾病重叠诊断及治疗指南2023（第2版）概要
Shigeo Muro,Kazuya Tanimura,Mitsuhiro Yamada et al.
Shigeo Muro et al.
Many patients have overlapping features of asthma and chronic obstructive pulmonary disease (COPD), but not all of them receive appropriate treatment for both conditions. The Japanese Respiratory Society published the guidelines on the diag...
Corrigendum to "Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease" [Respir Invest, Volume 64, Issue 1, January 2026, 101340] [0.03%]
关于“吸入曲前列尼尔治疗与间质性肺病相关的日本肺动脉高压患者长期疗效”[Respir Investig第64卷，第1期，2026年1月，101340]的勘误表
Yasuhiro Kondoh,Takashi Ogura,Osamu Nishiyama et al.
Yasuhiro Kondoh et al.
Published Erratum
Respiratory investigation. 2026 Jan 6:101365. DOI:10.1016/j.resinv.2025.101365 2026